Boyce Sarah

CIK 00016293838 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001629383

Recent Transactions

50 trades

Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−386,015→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−400,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−425,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−165,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−300,000→ 0 total
Award
Atrium Therapeutics, Inc.
Stock Option (Right to Buy)
2026-02-27+20,000→ 20,000 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−474,861→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−200,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−300,000→ 0 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−6,394→ 277,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−7,993→ 269,007 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-07$72.23/sh−8,576→ 283,394 total
Gift
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-12-18−29,159→ 291,970 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-12-17+31,000→ 336,871 total
Tax Payment
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-12-17$71.87/sh−15,742→ 321,129 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-05$49.95/sh−50,000→ 305,871 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-09-05−50,000→ 1,022,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-05$1.24/sh+50,000→ 355,871 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-28−25,000→ 1,072,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-28$1.24/sh+25,000→ 330,871 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-28$49.39/sh−25,000→ 305,871 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2025-06-26+14,750→ 14,750 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-03-20$31.06/sh−31,540→ 305,871 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.59/sh−5,659→ 337,411 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.59/sh−4,738→ 343,070 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-06+82,500→ 347,808 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-01-06+165,000→ 165,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-12-18$32.66/sh−31,855→ 265,308 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-23$44.00/sh−32,880→ 234,663 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-19+62,500→ 267,543 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-19+62,500→ 297,163 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-08-06$43.35/sh−28,000→ 205,043 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-08-06−28,000→ 461,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-08-06$1.24/sh+28,000→ 233,043 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-07-09$1.24/sh+28,000→ 233,043 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-07-09−28,000→ 489,015 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-07-09$39.93/sh−28,000→ 205,043 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-06-24+29,500→ 29,500 total
Exercise/Conversion
OmniAb, Inc.$OABIW
Restricted Stock Units
2024-06-18−20,000→ 0 total
Exercise/Conversion
OmniAb, Inc.$OABIW
Common Stock
2024-06-18+20,000→ 68,381 total
Award
OmniAb, Inc.$OABIW
Stock Option (right to buy)
2024-06-18+40,000→ 40,000 total
Award
OmniAb, Inc.$OABIW
Restricted Stock Units
2024-06-18+20,000→ 20,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-18$39.13/sh−32,074→ 142,543 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-17+62,500→ 205,043 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-17+62,500→ 174,617 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-14$1.24/sh+35,767→ 147,884 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-06-14−35,767→ 517,015 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-14$40.08/sh−35,767→ 112,117 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-13$40.08/sh−164,233→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-13$1.24/sh+164,233→ 276,350 total

Companies

Recent Filings

Address

C/O ATRIUM THERAPEUTICS, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125

SAN DIEGO, CA, 92121

View on SEC.gov